Subscribe To
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...
January 25, 2022, 8:43 am
Diamedica therapeutics to present research at international stroke conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...
January 25, 2022, 8:43 am
Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...
January 25, 2022, 8:15 am
Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...
January 25, 2022, 8:15 am
Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...
January 25, 2022, 8:15 am
5 psychedelic therapeutics decisions coming in 2022
Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...
January 25, 2022, 7:35 am
5 psychedelic therapeutics decisions coming in 2022
Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...
January 25, 2022, 7:35 am
5 psychedelic therapeutics decisions coming in 2022
Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...
January 25, 2022, 7:35 am
Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program
The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...
January 25, 2022, 7:05 am
Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program
The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...
January 25, 2022, 7:05 am
Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program
The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...
January 25, 2022, 7:05 am
J&j shares down 1.3% premarket after q4 revenue lags consensus
Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...
January 25, 2022, 6:45 am
J&j shares down 1.3% premarket after q4 revenue lags consensus
Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...
January 25, 2022, 6:45 am
J&j shares down 1.3% premarket after q4 revenue lags consensus
Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...
January 25, 2022, 6:45 am
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why
Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...
January 24, 2022, 10:28 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
January 24, 2022, 6:45 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
January 24, 2022, 6:45 pm
Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...
January 24, 2022, 6:45 pm